Dec 29, 2019 06:03 PM
https://gizmodo.com/fda-approves-the-fir...1840680279
INTRO: People dealing with painful migraines will soon have a new treatment available. This week, the Food and Drug Administration approved a unique drug meant to shorten acute migraine episodes. It’s the latest treatment for a condition that’s historically had few.
The drug is called Ubrelvy (compound name Ubrogepant), licensed by the pharmaceutical company Allergan. It works by blocking the effects of a protein called calcitonin gene–related peptide (CGRP), which has been shown to be important to triggering and sustaining migraines.
In 2018, the FDA approved the first specialized preventive treatment for migraines called Aimovig, which also works by blocking CRGP. But Ubrelvy is the first drug of its kind designed to treat migraines as they’re happening, according to the FDA. It’s also taken orally as opposed to Aimovig and similar drugs, which are taken through injection... (MORE)
INTRO: People dealing with painful migraines will soon have a new treatment available. This week, the Food and Drug Administration approved a unique drug meant to shorten acute migraine episodes. It’s the latest treatment for a condition that’s historically had few.
The drug is called Ubrelvy (compound name Ubrogepant), licensed by the pharmaceutical company Allergan. It works by blocking the effects of a protein called calcitonin gene–related peptide (CGRP), which has been shown to be important to triggering and sustaining migraines.
In 2018, the FDA approved the first specialized preventive treatment for migraines called Aimovig, which also works by blocking CRGP. But Ubrelvy is the first drug of its kind designed to treat migraines as they’re happening, according to the FDA. It’s also taken orally as opposed to Aimovig and similar drugs, which are taken through injection... (MORE)